| |
| |
|
| Insider
Information: |
Andreotti Lamberto |
| Relationship: |
|
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
1,011,868 |
|
|
Indirect Shares
|
241,273 |
|
|
| Direct
Value |
$43,876,119 |
|
|
|
Indirect Value
|
$10,642,552 |
|
|
| Total
Shares |
1,253,141 |
|
|
| Total
Value |
$54,518,671 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 14.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
Director |
2017-04-07 |
935,571 |
2017-04-07 |
241,273 |
Premium* |
|
|
Mead Johnson Nutrition Co |
MJN |
Director |
2009-12-23 |
19,609 |
2009-02-17 |
0 |
Premium* |
|
|
DuPont de Nemours Inc |
DD |
Director |
2017-08-31 |
0 |
2012-08-02 |
0 |
Premium* |
|
|
Dowdupont Inc. |
DWDP |
Director |
2019-05-21 |
22,231 |
|
0 |
Premium* |
|
|
Corteva, Inc. |
CTVA |
|
2024-04-26 |
34,457 |
2019-06-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
Pres & Chief Operating Officer |
• • – |
2009-12-23 |
4 |
S |
$0.00 |
$0 |
D/D |
(21,558) |
181,719 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2012-09-05 |
4 |
S |
$33.05 |
$3,817,275 |
D/D |
(115,500) |
398,991 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2013-06-04 |
4 |
S |
$47.74 |
$4,774,000 |
D/D |
(100,000) |
478,562 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2014-02-11 |
4 |
S |
$52.66 |
$4,532,572 |
D/D |
(86,075) |
500,487 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2014-03-10 |
4 |
S |
$55.52 |
$5,552,260 |
D/D |
(100,000) |
630,783 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2015-01-29 |
4 |
S |
$61.14 |
$5,518,001 |
D/D |
(90,246) |
383,063 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Director |
– • – |
2015-08-03 |
4 |
S |
$64.75 |
$20,589,328 |
D/D |
(315,000) |
570,074 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Director |
– • – |
2016-05-02 |
4 |
S |
$71.87 |
$16,870,792 |
D/D |
(234,720) |
436,794 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Director |
– • – |
2016-05-04 |
4 |
S |
$70.48 |
$817,568 |
D/D |
(11,600) |
425,194 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Director |
– • – |
2016-05-05 |
4 |
S |
$70.59 |
$818,844 |
D/D |
(11,600) |
413,594 |
0 |
- |
|
| DWDP |
Dowdupont Inc. |
Director |
– • – |
2018-03-08 |
4 |
S |
$70.31 |
$5,976 |
D/D |
(85) |
18,632 |
0 |
- |
|
| CTVA |
Corteva, Inc. |
Director |
– • – |
2020-02-03 |
4 |
S |
$29.11 |
$2,620 |
D/D |
(90) |
14,348 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
EVP BMS & President WW Pharm |
• – – |
2007-05-08 |
4 |
OE |
$28.90 |
$867,000 |
D/D |
30,000 |
287,497 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Pres, COO & CEO Designate |
• • – |
2010-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
72,043 |
250,803 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Pres, COO & CEO Designate |
• • – |
2010-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,600 |
223,296 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2011-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
116,000 |
312,089 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2011-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,348 |
269,887 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2011-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,452 |
269,384 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2011-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,600 |
272,222 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2011-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,989 |
278,235 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2012-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,530 |
305,642 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2012-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,349 |
312,575 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2012-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,344 |
317,263 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2012-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,453 |
319,495 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2012-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
109,780 |
425,513 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
